Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification.
Narayanan S, Vuckovic S, Bergman O, Wirka R, Verdezoto Mosquera J, Chen QS, Baldassarre D, Tremoli E, Veglia F, Lengquist M, Aherahrrou R, Razuvaev A, Gigante B, Björck HM, Miller CL, Quertermous T, Hedin U, Matic L.
Narayanan S, et al. Among authors: chen qs.
Eur Heart J. 2024 Nov 18:ehae768. doi: 10.1093/eurheartj/ehae768. Online ahead of print.
Eur Heart J. 2024.
PMID: 39552248